Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes

Background: Glucagon-like peptide-1 (GLP-1) agonists have emerged as a powerful diabetic treatment adjunct; however, its effects on outcomes following total knee arthroplasty (TKA) are not well known. The purpose of this study was to compare the risk of complications after TKA in patients with type-...

Descrición completa

Detalles Bibliográficos

Principais autores:	Kevin Y. Heo, BS, Rahul K. Goel, MD, Andrew Fuqua, BS, Jeffrey S. Holmes, MD, Brian T. Muffly, MD, Greg A. Erens, MD, Jacob M. Wilson, MD, Ajay Premkumar, MD, MPH
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2024-12-01
Series:	Arthroplasty Today
Assuntos:	GLP-1 receptor agonist Glucagon-like Peptide-1 receptor agonist Complications Total knee arthroplasty Diabetes
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2352344124001912
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!